PPP2R1A mutations portend improved survival after cancer immunotherapy.

Nature · 2025 · PMC12350166 · PMID 40604275

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, B cells (CD20 + ), particularly proliferating B cells (CD20 + Ki-67 + ) and germinal centre B cells (CD20 + CD21 + Ki-67 + ), showed a trend of higher densities in PPP2R1A -mutant samples, despite the small cohort size (Fig. 3b,c and Extended Data Fig. 5b,c ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.